logo-loader

BetterLife Pharma able to demonstrate BETR-001 Anti-Depressant activity in Preclinical Models

Published: 08:57 06 Apr 2022 EDT

BetterLife Pharma CEO Ahmad Doroudian joined Steve Darling from Proactive to share news the company has obtained additional positive data confirming the anti-depressant activity of its lead compound 2-bromo-LSD in preclinical models of depression. Doroudian telling Proactive the current study evaluated the anti-depressant activity of BETR-001 on depressive-like behavior of mice in a forced swim test. The amount of time mice spend immobile was significantly reduced 24 hours after treatment with single dose of BETR-001.

ARway.ai announces multiple new SaaS developer contracts in both the United...

ARway.ai (CSE:ARWY, OTCQB:ARWYF) Chief Executive Officer Evan Gappelberg joined Steve Darling from Proactive to announce multiple new SaaS developer sign-ups for its augmented reality experience platform, focusing on AR indoor navigation. These partnerships represent significant milestones in...

2 hours, 6 minutes ago